Efficacy and Safety of mRNA-Based COVID-19 Vaccines in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis.

Vaccines (Basel) · 2026 · PMC12846407 · PMID 41600988

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

The pooled seroconversion proportions generally followed a decreasing trend, with the highest rates observed in liver transplant recipients (0.8; 95% CI: 0.72, 0.86; refer to Figure 5 ), followed closely by kidney transplant recipients (0.47; 95% CI: 0.39, 0.54; refer to Electronic Supplementary Figure S3 ) and heart transplants (0.46; 95% CI: 0.27, 0.66; refer to Figure 6 ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.